Neuralink, Elon Musk’s brain implant company, said on Thursday it had received approval from the Food and Drug Administration to start its first human clinical trial.
On several occasions since 2019, billionaire Elon Musk has predicted that his brain-chip company will soon get FDA approval for human trials. But the corporate’s application was rejected in early 2022, and the corporate worked through the agency’s concerns in regards to the safety of the experimental implant.
“That is the results of the amazing work of the Neuralink team in close cooperation with the FDA and is a vital first step that may at some point allow our technology to assist many individuals.” Neuralink said in a tweet Thursday.
Neuralink added that the corporate is just not yet open to a clinical trial.
Neuralink is developing a brain implant that it hopes will help paralyzed people walk again and treat other neurological ailments.
![Neuralink and Elon Musk logos](https://nypost.com/wp-content/uploads/sites/2/2023/05/NYPICHPDPICT000008808981.jpg?w=1024)
![Human brain illustration](https://nypost.com/wp-content/uploads/sites/2/2023/05/NYPICHPDPICT000010550654.jpg?w=1024)
The FDA didn’t immediately reply to a Reuters request for comment.
Musk said he feels comfortable implanting a chip into the brain of one among his own children if the necessity arises.